IN8bio, Inc. Rings the Closing Bell

ABOUT THIS EVENT

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T-cell therapies utilizing its DeltEx platform, visits the Nasdaq MarketSite in Times Square. 

In honor of the occasion, William Ho, President, CEO, and Co-founder, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore